Literature DB >> 6496710

Influence of renal nerves on noradrenergic responses to changes in arterial pressure.

K P Patel, R L Kline.   

Abstract

Renal denervation has been shown previously to lower the increased arterial pressure as well as the increased hypothalamic and peripheral noradrenergic activity found in neurogenic and Goldblatt models of experimental hypertension. In the present study conscious Wistar rats with or without renal nerves were subjected to 60 min of saline infusion (controls), hypotension (intravenous sodium nitroprusside), or hypertension (intravenous phenylephrine HCl). Changes in the turnover of norepinephrine (NE) in the anterior hypothalamus, posterior hypothalamus, kidney, intestine, and skeletal muscle were assessed by measuring the decline of NE concentration 90 min after administration of alpha-methyl tyrosine. There was a significant increase in NE turnover in the posterior hypothalamus and all peripheral organs examined in the nitroprusside-infused group with intact renal nerves. In renal-denervated animals, acute hypotension produced similar changes in NE turnover in peripheral organs, but no significant change was observed in the posterior hypothalamus. In the acutely hypertensive group with intact renal nerves, there was no significant change in NE turnover in the hypothalamic sections or the peripheral organs; however, the turnover of NE was significantly decreased in both the anterior and posterior hypothalamus of the renal-denervated hypertensive group. Overall these studies suggest the presence of an interaction between inhibitory influences from baroreceptor afferents and excitatory influences from renal afferents on noradrenergic activity in the hypothalamus and changes in noradrenergic activity in hypothalamic structures may not be directly related to changes in sympathetic outflow.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496710     DOI: 10.1152/ajpregu.1984.247.4.R615

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Central administration of kisspeptin-10 inhibits natriuresis and diuresis induced by blood volume expansion in anesthetized male rats.

Authors:  Xu Han; Ming Yan; Xiao-fei An; Ming He; Jiang-yi Yu
Journal:  Acta Pharmacol Sin       Date:  2009-12-21       Impact factor: 6.150

2.  Activation of afferent renal nerves modulates RVLM-projecting PVN neurons.

Authors:  Bo Xu; Hong Zheng; Xuefei Liu; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-30       Impact factor: 4.733

3.  Increased renal ENaC subunits and sodium retention in rats with chronic heart failure.

Authors:  Hong Zheng; Xuefei Liu; U S Rao; Kaushik P Patel
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-15

4.  Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).

Authors:  S Ye; S Nosrati; V M Campese
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

Review 5.  Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.

Authors:  Kaushik P Patel; Kenichi Katsurada; Hong Zheng
Journal:  Circ Res       Date:  2022-05-12       Impact factor: 23.213

6.  Renal Denervation Improves Exaggerated Sympathoexcitation in Rats With Heart Failure: A Role for Neuronal Nitric Oxide Synthase in the Paraventricular Nucleus.

Authors:  Kaushik P Patel; Bo Xu; Xuefei Liu; Neeru M Sharma; Hong Zheng
Journal:  Hypertension       Date:  2016-05-16       Impact factor: 10.190

7.  Specific Afferent Renal Denervation Prevents Reduction in Neuronal Nitric Oxide Synthase Within the Paraventricular Nucleus in Rats With Chronic Heart Failure.

Authors:  Hong Zheng; Kenichi Katsurada; Xuefei Liu; Mark M Knuepfer; Kaushik P Patel
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

8.  GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation.

Authors:  Kenichi Katsurada; Shyam S Nandi; Hong Zheng; Xuefei Liu; Neeru M Sharma; Kaushik P Patel
Journal:  Cardiovasc Diabetol       Date:  2020-05-08       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.